Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Allos Therapeutics completes patient enrollment for RSR-13 trial in lung cancer

Aug. 4, 2000

European Commission approves Myocet as treatment of metastatic breast cancer

Aug. 4, 2000

Bavarian Nordic initiates phase I/II trial of metastatic malignant melanoma treatment

Aug. 3, 2000

NIH offers apoptosis-inducing gene product for licensing

Aug. 3, 2000

CuraGen researchers identify SECX polypeptides useful for diagnosis, treatment of cancer

Aug. 2, 2000

Apoptosis-inducing retinamides described by Roche

Aug. 2, 2000

Novel tubulin-binding compounds designed at Tularik

Aug. 2, 2000

Antisense modulators of human sentrin useful for cancer and primary biliary cirrhosis

Aug. 2, 2000

GPC Biotech initiates strategic alliance with Cytovia for oncology compound

Aug. 2, 2000

Additional pivotal trial data reported for IntraDose

Aug. 2, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...